Raymond F Schinazi Selected Research

Nucleosides

1/2022	Baricitinib attenuates the proinflammatory phase of COVID-19 driven by lung-infiltrating monocytes.
4/2021	Baicalein and Baicalin Inhibit SARS-CoV-2 RNA-Dependent-RNA Polymerase.
1/2021	Moving Fast Toward Hepatitis B Virus Elimination.
1/2021	Comparison of anti-SARS-CoV-2 activity and intracellular metabolism of remdesivir and its parent nucleoside.
3/2020	Synthesis of 4'-Substituted-2'-Deoxy-2'-α-Fluoro Nucleoside Analogs as Potential Antiviral Agents.
1/2020	7-Deaza-7-fluoro-2'-C-methyladenosine inhibits Zika virus infection and viral-induced neuroinflammation.
1/2020	Potent in vitro activity of β-D-4'-chloromethyl-2'-deoxy-2'-fluorocytidine against Nipah virus.
1/2019	Nucleoside Analogs with Selective Antiviral Activity against Dengue Fever and Japanese Encephalitis Viruses.
10/2017	Metabolism of Nucleosides and Nucleotides Prodrugs.
12/2016	Metabolism, Biochemical Actions, and Chemical Synthesis of Anticancer Nucleosides, Nucleotides, and Base Analogs.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Raymond F Schinazi Research Topics

Disease

35	Infections 01/2022 - 05/2002
16	Neoplasms (Cancer) 10/2021 - 01/2004
14	COVID-19 12/2022 - 05/2020
14	Acquired Immunodeficiency Syndrome (AIDS) 01/2022 - 04/2002
12	HIV Infections (HIV Infection) 10/2022 - 01/2003
9	Inflammation (Inflammations) 01/2022 - 05/2015
6	Body Weight (Weight, Body) 12/2021 - 01/2005
5	Virus Diseases (Viral Diseases) 11/2021 - 07/2014
5	Hepatocellular Carcinoma (Hepatoma) 06/2021 - 07/2005
5	Chronic Hepatitis C 06/2021 - 12/2013
5	Chronic Hepatitis B 01/2021 - 05/2002
4	Hepatitis C 02/2014 - 01/2006
3	Viremia 01/2014 - 09/2007
3	Parasitic Diseases (Parasitic Disease) 12/2006 - 06/2003
2	Fibrosis (Cirrhosis) 01/2021 - 10/2016
2	Neuroinflammatory Diseases 01/2020 - 09/2019
2	Zika Virus Infection 01/2020 - 01/2017
2	Encephalitis (Encephalitis, Rasmussen) 01/2020 - 01/2016
2	Gliosis 09/2019 - 01/2016
2	Rheumatoid Arthritis 09/2019 - 01/2014
2	Dengue (Dengue Fever) 01/2019 - 01/2006
2	Drug-Related Side Effects and Adverse Reactions 01/2019 - 12/2012
2	Ovarian Neoplasms (Ovarian Cancer) 01/2018 - 11/2017
2	Primary Myelofibrosis (Myelosclerosis) 01/2016 - 01/2014
2	Liver Diseases (Liver Disease) 07/2014 - 11/2013
2	Communicable Diseases (Infectious Diseases) 07/2014 - 12/2006
2	Opportunistic Infections (Opportunistic Infection) 05/2010 - 08/2004
2	Prostatic Neoplasms (Prostate Cancer) 04/2010 - 01/2004
2	T-Cell Lymphoma (Lymphoma, T Cell) 06/2007 - 07/2005
2	Diarrhea 01/2003 - 12/2002
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2022
1	Disease Progression 01/2022
1	Gastroenteritis 12/2020
1	Hepatitis B 03/2020
1	Cardiotoxicity 01/2020

Drug/Important Bio-Agent (IBA)

27	NucleosidesIBA 01/2022 - 01/2003
25	Antiviral Agents (Antivirals)IBA 12/2022 - 01/2003
16	Pharmaceutical PreparationsIBA 12/2022 - 05/2002
8	baricitinibIBA 01/2022 - 09/2019
8	RNA (Ribonucleic Acid)IBA 10/2021 - 01/2003
7	ruxolitinibIBA 01/2022 - 01/2014
7	CytokinesIBA 12/2021 - 09/2019
6	InterferonsIBA 01/2022 - 07/2014
5	DNA (Deoxyribonucleic Acid)IBA 12/2020 - 09/2007
5	NucleotidesIBA 01/2020 - 05/2010
5	Lamivudine (Epivir)FDA Link 01/2007 - 05/2002
4	remdesivirIBA 01/2022 - 10/2020
4	Janus Kinase InhibitorsIBA 01/2022 - 01/2016
4	Proteins (Proteins, Gene)FDA Link 11/2021 - 05/2020
4	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 11/2015 - 06/2005
3	RacivirIBA 01/2022 - 05/2002
3	EnzymesIBA 10/2021 - 01/2015
3	Ribavirin (Virazole)FDA LinkGeneric 06/2021 - 04/2004
3	VaccinesIBA 01/2021 - 01/2017
3	RNA-Dependent RNA Polymerase (RNA Dependent RNA Polymerase)IBA 01/2021 - 02/2014
3	SofosbuvirIBA 01/2020 - 07/2014
3	Reverse Transcriptase InhibitorsIBA 11/2015 - 07/2012
2	Emtricitabine (Emtriva)FDA Link 01/2022 - 12/2012
2	SAM Domain and HD Domain-Containing Protein 1IBA 01/2022 - 10/2021
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2021
2	Aspartic Acid (Aspartate)FDA Link 10/2021 - 12/2020
2	Histidine (L-Histidine)FDA Link 10/2021 - 12/2020
2	ChemokinesIBA 01/2021 - 09/2020
2	Interferon-alpha (Interferon Alfa)IBA 01/2021 - 04/2004
2	ProdrugsIBA 01/2021 - 01/2008
2	AntigensIBA 01/2021 - 11/2013
2	Peptide Hydrolases (Proteases)FDA Link 01/2019 - 01/2018
2	Viral RNAIBA 01/2018 - 07/2010
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2018 - 11/2017
2	Protease Inhibitors (Protease Inhibitor)IBA 10/2016 - 12/2013
2	SimeprevirIBA 10/2016 - 07/2014
2	ThymidineIBA 07/2012 - 05/2010
2	Stavudine (Zerit)FDA LinkGeneric 11/2011 - 03/2009
2	phytobacteriomycin (PBM)IBA 06/2007 - 07/2005
2	triphosphoric acid (triphosphate)IBA 06/2007 - 05/2002
2	Biological ProductsIBA 12/2006 - 08/2004
2	UridineIBA 11/2006 - 06/2005
2	Fluorouracil (Carac)FDA LinkGeneric 11/2006 - 06/2005
2	AlkaloidsIBA 08/2004 - 06/2003
1	Chloroquine (Aralen)FDA LinkGeneric 12/2022
1	Viral ProteinsIBA 01/2022
1	Lipopolysaccharide ReceptorsIBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	Cytochrome P-450 CYP3AIBA 12/2021
1	Janus Kinase 1IBA 12/2021
1	efavirenz (Sustiva)FDA Link 12/2021
1	LigandsIBA 11/2021
1	baicalinIBA 04/2021
1	baicaleinIBA 04/2021
1	GS-441524IBA 01/2021
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021
1	Immunoglobulin M (IgM)IBA 05/2020
1	Immunoglobulin G (IgG)IBA 05/2020

Therapy/Procedure

24	Therapeutics 01/2022 - 05/2002
9	Highly Active Antiretroviral Therapy (HAART) 10/2022 - 05/2002
3	Art Therapy 01/2018 - 01/2015
2	Drug Therapy (Chemotherapy) 01/2019 - 11/2017
2	Oral Administration 09/2007 - 07/2007
2	Boron Neutron Capture Therapy 09/2005 - 01/2004